# Prairie Operating Co.: financial statements, quarterly

PROP · Nasdaq · CIK 1162896 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prop.md) · [Financials](/companies/prop/financials.md) · [Filings](/companies/prop/filings.md) · [Insiders](/companies/prop/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prop/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.5](/filings/0001493152-23-040854.md) | [0.9 d](/filings/0001493152-24-010692.md) | not reported | not reported | [0.0](/filings/0001140361-25-042353.md) | [7.9 d](/filings/0001140361-26-012036.md) | [13.6](/filings/0001140361-26-021301.md) | [68.1](/filings/0001140361-26-033218.md) | [77.7](/filings/0001140361-25-042353.md) | [83.0 d](/filings/0001140361-26-012036.md) | [83.4](/filings/0001140361-26-021301.md) | [98.9](/filings/0001140361-26-033218.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(6.3)](/filings/0001493152-24-044178.md) | [(7.3) d](/filings/0001493152-25-009423.md) | [(8.0)](/filings/0001641172-25-010843.md) | [(8.6)](/filings/0001641172-25-023187.md) | [(8.8)](/filings/0001140361-25-042353.md) | [(1.1) d](/filings/0001140361-26-012036.md) | [1.8](/filings/0001641172-25-010843.md) | [18.9](/filings/0001641172-25-023187.md) | [27.0](/filings/0001140361-25-042353.md) | [17.8 d](/filings/0001140361-26-012036.md) | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [1.2](/filings/0001641172-25-010843.md) | [8.1](/filings/0001641172-25-023187.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001140361-25-042353.md) | [0.0 d](/filings/0001140361-26-012036.md) | [0.0](/filings/0001140361-26-021301.md) | [0.0](/filings/0001140361-26-033218.md) | [0.0](/filings/0001140361-25-042353.md) | [21.7 d](/filings/0001140361-26-012036.md) | [(38.4)](/filings/0001140361-26-021301.md) | [19.8](/filings/0001140361-26-033218.md) |
| Net income | $m | [(34.4)](/filings/0001493152-24-044178.md) | [(23.5) d](/filings/0001493152-25-009423.md) | [(9.0)](/filings/0001140361-25-042353.md) | [(8.5)](/filings/0001140361-25-042353.md) | [(11.4)](/filings/0001140361-25-042353.md) | [(11.9) d](/filings/0001140361-26-012036.md) | [(2.6)](/filings/0001140361-26-033218.md) | [35.7](/filings/0001140361-26-033218.md) | [1.3](/filings/0001140361-25-042353.md) | [(2.3) d](/filings/0001140361-26-012036.md) | [(153)](/filings/0001140361-26-033218.md) | [109](/filings/0001140361-26-033218.md) |
| Diluted EPS | $ per share | [(5.24)](/filings/0001493152-24-044178.md) | not reported | [(0.90)](/filings/0001641172-25-010843.md) | [(3.49)](/filings/0001641172-25-023187.md) | [(0.68)](/filings/0001140361-25-042353.md) | not reported | [(3.49)](/filings/0001140361-26-021301.md) | [0.18](/filings/0001140361-26-033218.md) | [(0.44)](/filings/0001140361-25-042353.md) | not reported | [(2.16)](/filings/0001140361-26-021301.md) | [0.23](/filings/0001140361-26-033218.md) |
| Basic EPS | $ per share | [(5.24)](/filings/0001493152-24-044178.md) | not reported | [(0.90)](/filings/0001641172-25-010843.md) | [(3.49)](/filings/0001641172-25-023187.md) | [(0.68)](/filings/0001140361-25-042353.md) | not reported | [(3.49)](/filings/0001140361-26-021301.md) | [1.04](/filings/0001140361-26-033218.md) | [(0.44)](/filings/0001140361-25-042353.md) | not reported | [(2.16)](/filings/0001140361-26-021301.md) | [1.75](/filings/0001140361-26-033218.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | period not labelled (2024-01-23) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.0](/filings/0001493152-25-009423.md) | [1.0](/filings/0001641172-25-023187.md) | [4.0](/filings/0001493152-24-018911.md) | [2.2](/filings/0001493152-24-030880.md) | [40.1](/filings/0001493152-24-044178.md) | [5.2](/filings/0001140361-26-012036.md) | [15.0](/filings/0001641172-25-010843.md) | [10.7](/filings/0001641172-25-023187.md) | [10.6](/filings/0001140361-25-042353.md) | [0.0](/filings/0001140361-26-033218.md) | [0.3](/filings/0001140361-26-021301.md) | [0.0](/filings/0001140361-26-033218.md) |
| Current assets | $m | [13.5](/filings/0001493152-25-009423.md) | not reported | [6.2](/filings/0001493152-24-018911.md) | [4.6](/filings/0001493152-24-030880.md) | [57.1](/filings/0001493152-24-044178.md) | [18.3](/filings/0001140361-26-012036.md) | [71.9](/filings/0001641172-25-010843.md) | [97.4](/filings/0001641172-25-023187.md) | [121](/filings/0001140361-25-042353.md) | [79.7](/filings/0001140361-26-033218.md) | [58.3](/filings/0001140361-26-021301.md) | [41.9](/filings/0001140361-26-033218.md) |
| Total assets | $m | [45.7](/filings/0001493152-25-009423.md) | not reported | [46.5](/filings/0001493152-24-018911.md) | [48.2](/filings/0001493152-24-030880.md) | [107](/filings/0001493152-24-044178.md) | [157](/filings/0001140361-26-012036.md) | [775](/filings/0001641172-25-010843.md) | [859](/filings/0001641172-25-023187.md) | [940](/filings/0001140361-25-042353.md) | [945](/filings/0001140361-26-033218.md) | [959](/filings/0001140361-26-021301.md) | [1,005](/filings/0001140361-26-033218.md) |
| Current liabilities | $m | [5.4](/filings/0001493152-25-009423.md) | not reported | [8.6](/filings/0001493152-24-018911.md) | [12.5](/filings/0001493152-24-030880.md) | [45.0](/filings/0001493152-24-044178.md) | [63.0](/filings/0001140361-26-012036.md) | [127](/filings/0001641172-25-010843.md) | [162](/filings/0001641172-25-023187.md) | [145](/filings/0001140361-25-042353.md) | [126](/filings/0001140361-26-033218.md) | [239](/filings/0001140361-26-021301.md) | [167](/filings/0001140361-26-033218.md) |
| Total liabilities | $m | [5.5](/filings/0001493152-25-009423.md) | not reported | [8.9](/filings/0001493152-24-018911.md) | [12.7](/filings/0001493152-24-030880.md) | [45.9](/filings/0001493152-24-044178.md) | [104](/filings/0001140361-26-012036.md) | [553](/filings/0001641172-25-010843.md) | [600](/filings/0001641172-25-023187.md) | [679](/filings/0001140361-25-042353.md) | [678](/filings/0001140361-26-033218.md) | [836](/filings/0001140361-26-021301.md) | [739](/filings/0001140361-26-033218.md) |
| Long-term debt | $m | [2.0](/filings/0001493152-23-040854.md) | not reported | not reported | not reported | not reported | [28.0](/filings/0001641172-25-023187.md) | [377](/filings/0001641172-25-010843.md) | [387](/filings/0001641172-25-023187.md) | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [40.2](/filings/0001140361-26-012036.md) | not reported | [37.7](/filings/0001140361-25-042353.md) | [35.5](/filings/0001140361-25-042353.md) | [61.3](/filings/0001140361-25-042353.md) | [52.8](/filings/0001140361-26-033218.md) | [34.0](/filings/0001140361-26-033218.md) | [94.2](/filings/0001140361-26-033218.md) | [102](/filings/0001140361-25-042353.md) | [130](/filings/0001140361-26-033218.md) | [0.4](/filings/0001140361-26-033218.md) | [223](/filings/0001140361-26-033218.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.9) d](/filings/0001493152-24-044178.md) | [(4.0) d](/filings/0001493152-25-009423.md) | [(3.3)](/filings/0001641172-25-010843.md) | [(5.1) d](/filings/0001641172-25-023187.md) | [2.8 d](/filings/0001140361-25-042353.md) | [(3.7) d](/filings/0001140361-26-012036.md) | [16.9](/filings/0001140361-26-021301.md) | [(7.2) d](/filings/0001140361-26-033218.md) | [57.7 d](/filings/0001140361-25-042353.md) | [86.5 d](/filings/0001140361-26-012036.md) | [42.3](/filings/0001140361-26-021301.md) | [52.0 d](/filings/0001140361-26-033218.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001493152-23-040854.md) | [0.0 d](/filings/0001493152-24-010692.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2020 (2020-09-30) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3.5](/filings/0001493152-21-028266.md) | [3.5](/filings/0001493152-21-011634.md) | [3.6](/filings/0001493152-21-019734.md) | [5.6](/filings/0001493152-21-028266.md) | [112](/filings/0001493152-23-027957.md) | [6.6](/filings/0001493152-23-040854.md) | [16.8](/filings/0001140361-25-042353.md) | [26.8](/filings/0001140361-26-021301.md) | [198](/filings/0001140361-26-033218.md) | [50.6](/filings/0001140361-25-042353.md) | [80.6](/filings/0001140361-26-021301.md) | [186](/filings/0001140361-26-033218.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 112,798,010 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0001140361-26-033218.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.